The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

PERSPECTIVES

What is new in the armamentarium of coronary surgeons to compete with PCI?

EuroIntervention 2018;14:e387-e389 published online e-edition July 2018. DOI: 10.4244/EIJV14I4A69

1. Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York City, NY, USA; 2. University of Oxford, Oxford, United Kingdom


In the last two decades, the comparison between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in the treatment of patients with multivessel and left main disease has been the object of at least a dozen large randomised controlled trials (RCTs).

One of the problems in the PCI vs. CABG debate is that, due to the continuous improvement in the technical and technological aspects of the two procedures, most of the comparative analyses are outdated soon after (or sometimes even at the moment of) their publication.

We herein describe three recent findings that will most ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure